
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

Volumetric muscle loss (VML) represents a severe clinical challenge characterized by the irrecoverable loss of skeletal muscle mass and persistent functional deficits. Emerging research into 17β-estradiol muscle recovery has revealed that a disrupted cellular redox homeostasis is a central attribute of the metabolic dysfunction following such injuries. This disruption often leads to excessive reactive oxygen species (ROS) emissions and chronic oxidative stress, which further hinders the regenerative process.
A recent study published in the American Journal of Physiology-Cell Physiology aimed to define how ovarian hormones, specifically 17β-estradiol (17β-E2), drive mitochondrial bioenergetic and redox balance after VML injury. Researchers randomized female mice into experimental and control groups to evaluate the effects of hormone loss through ovariectomy (OVX) and subsequent repletion. The findings suggest that 17β-E2 is essential for maintaining antioxidant buffering capacity (AoxBC) and mitigating mitochondrial gene suppression.
In intact females, the study observed that ROS emissions were initially higher during the first 14 days post-injury, yet the antioxidant capacity recovered faster than previously noted in males. Conversely, chronic depletion of 17β-estradiol exacerbated VML-induced metabolic dysfunction. This resulted in diminished AoxBC and significantly greater ROS emissions. However, when the team administered 17β-E2 repletion, they noted an immediate attenuation of ROS emissions by day 7. Furthermore, this treatment led to sustained improvements in mitochondrial respiratory capacity and bioenergetic efficiency for up to 60 days.
Beyond local muscle recovery, 17β-E2 depletion led to systemic issues such as impaired glucose tolerance and increased adiposity. The study demonstrated that 17β-E2 treatment successfully mitigated these metabolic risks. Transcriptomic analyses further indicated that the hormone contributes to resolving inflammation. Additionally, it helps enforce a temporal decoupling of cellular expansion and mitochondrial maturation, which is vital for effective tissue repair after traumatic injury.
It improves the mitochondrial bioenergetic efficiency and strengthens the antioxidant defense system, which reduces harmful oxidative stress at the site of injury.
Yes, the lack of ovarian hormones can lead to impaired glucose tolerance and increased fat accumulation following muscle trauma, as seen in the study models.
While this mouse study provides a molecular basis for the benefits of 17β-E2, clinical trials are necessary to confirm if hormone replacement therapy can safely enhance recovery in women with VML or similar injuries.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
1. Heo J et al. 17β-estradiol mitigates ovariectomy-induced defects in mitochondrial bioenergetics and redox balance after VML injury in female mice. Am J Physiol Cell Physiol. 2026 Jun 11. doi: 10.1152/ajpcell.00282.2026. PMID: 42275103.
2. Torres MJ et al. 17β-Estradiol Directly Lowers Mitochondrial Membrane Microviscosity and Improves Bioenergetic Function in Skeletal Muscle. Cell Metab. 2018 Jan 9;27(1):167-179.e7. doi: 10.1016/j.cmet.2017.10.003.
3. Collins BC et al. Estrogen regulates the satellite cell compartment in females. Cell Rep. 2019 Jul 9;28(2):368-381.e6. doi: 10.1016/j.celrep.2019.06.025.

A study highlights the critical role of 17β-estradiol in mitigating mitochondrial bioenergetic defects and redox imbalance following volumetric muscle loss (VML) injury. E2 repletion significantly improved antioxidant capacity and respiratory efficiency while preventing injury-induced metabolic dysfunction.
Today

A landmark study published in Cell Genomics reveals that overcrowding, poor sanitation, and socioeconomic inequality are primary drivers of global antimicrobial resistance. Reducing antibiotic consumption alone will not suffice, highlighting the urgent need for structural public health reforms by 2050.
Today

A new study reveals that hyperactivating the Hedgehog pathway with Smoothened Agonist (SAG) causes significant craniofacial development defects in mice. By disrupting cell proliferation and cell-cycle progression during a critical window, SAG exposure leads to cleft lip and other cranial abnormalities.
Today

A study of 221 patients reveals that IVUS guidance during intracoronary brachytherapy for in-stent restenosis significantly reduces target lesion revascularization (21% vs 37%) and major adverse cardiovascular events, ensuring better long-term procedural success and improved patient safety.
Today

Despite their expertise in ergonomics, physiotherapists face high rates of work-related musculoskeletal disorders. New research identifies low back pain and repetitive tasks as leading issues, with female practitioners showing significantly higher risk profiles compared to their male counterparts.
Today

A comprehensive pathological study reveals that medial and intimal calcification follow distinct, inverse distribution patterns in the lower extremities, with medial calcification significantly linked to chronic kidney disease.
Today